|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 901 New York Ave NW |
Address2 | Suite 515E |
City | Washington |
State | DC |
Zip Code | 20001-4432 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1967-12
|
||||||||
|
6. House ID# 317210000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lupe Gonzales Jr |
Date | 8/25/2022 12:15:42 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Opioids, pain management
Federal funding for Substance Use Disorder treatments
H.R.1384-Mainstreaming Addiction Treatment Act of 2021
H.R.4846-ALTO Reauthorization Act of 2021
S.445-Mainstreaming Addiction Treatment Act of 2021
S.2538-ALTO Reauthorization Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AUT
16. Specific lobbying issues
H.R.3164-Hot Cars Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Senior Congressional Lobbyist |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Federal funding to implement Alternatives to Opioids (ALTO) program
Federal funding to implement Preventing Overdoses While in Emergency Rooms (POWER) program
Federal funding to implement MISSION ZERO program
Federal funding to implement firearm injury prevention
Federal funding to implement Emergency Medical Services for Children (EMSC)
Federal funding for emergency medicine research activities
H.R.315-Medicare Sequester COVID Moratorium Act
H.R.2471-Consolidated Appropriations Act, 2022
H.R.4502-Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
H.R.5305-Extending Government Funding and Delivering Emergency Assistance Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act
H.R.1260-Bipartisan Solution to Cyclical Violence Act of 2021
H.R.1620-Violence Against Women Act Reauthorization Act of 2021
H.R.3164-Hot Cars Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
Access to emergency medical supplies (including Personal Protective Equipment, COVID-19 tests, ventilators, and medications) during COVID-19 public health emergency
H.R.1306-National Coronavirus Commission Act of 2021
H.R.2354-EMS Counts Act
H.R.3635-Strengthening America's Strategic National Stockpile Act of 2021
H.R.5703-Post-Disaster Mental Health Response Act
S.412-National Coronavirus Commission Act of 2021
S.1974-Strengthening Americas Strategic National Stockpile Act of 2021
S.2925-Strategic Planning for Emergency Medical Manufacturing Act
S.3677-Post-Disaster Mental Health Response Act
S.3799-PREVENT Pandemics Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Jeanne Slade
Director, NEMPAC and ACEP Grassroots Advocacy
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R.2418-Student Loan Forgiveness for Frontline Health Workers Act
H.R.4122-To amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program
S.3658-REDI Act, to amend the Higher Education Act of 1965 to provide for interest-free deferment on student loans for borrowers serving in a medical or dental internship or residency program
S.3828-Student Loan Forgiveness for Frontline Health Workers Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIR
16. Specific lobbying issues
Federal funding for firearms safety and injury prevention research
H.R.8-Bipartisan Background Checks Act of 2021
H.R.1446-Enhanced Background Checks Act of 2021
S. 2938-Bipartisan Safer Communities Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Reproductive health, physician-patient relationship, and EMTALA issues
H.R.1193-Cardiovascular Advances in Research and Opportunities Legacy Act
H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act
H.R.1205-Improving Mental Health Access from the Emergency Department Act of 2021
H.R.1260-Bipartisan Solution to Cyclical Violence Act of 2021
H.R.1324-Effective Suicide Screening and Assessment in the Emergency Department Act of 2021
H.R.1364-Parity Enforcement Act of 2021
H.R.1384-Mainstreaming Addiction Treatment Act of 2021
H.R.1620-Violence Against Women Act Reauthorization Act of 2021
H.R.3650-Improving Access to Medicare Coverage Act of 2021
H.R.4555-Oral Health Literacy and Awareness Act of 2021
H.R.7666-Restoring Hope for Mental Health
H.R.7850-Prevent BLEEDing Act of 2022
H.Res.656-Supporting the designation of September 17, 2021, as National Physician Suicide Awareness Day to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health issues
S.445-Mainstreaming Addiction Treatment Act of 2021
S.467-Effective Suicide Screening and Assessment in the Emergency Department Act of 2021
S.1133-Cardiovascular Advances in Research and Opportunities Legacy Act
S.2048-Improving Access to Medicare Coverage Act of 2021
S.2157-Improving Mental Health Access from the Emergency Department Act of 2021
S.2422-Bipartisan Solution to Cyclical Violence Act
S. 4269-Prevent BLEEDing Act
S.Res.364-Supporting the designation of September 17, 2021, as National Physician Suicide Awareness Day to raise awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health issues.
S.Res.557-A resolution recognizing the week of March 20 through March 26, 2022, as National Poison Prevention Week and encouraging communities across the United States to raise awareness of the dangers of poisoning and promote poison prevention.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
H.R.1364-Parity Enforcement Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Due process protections for emergency physicians
H.R.1195-Workplace Violence Prevention for Health Care and Social Service Workers Act
S. 4182-Workplace Violence Prevention for Health Care and Social Service Workers Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Federal funding for emergency medicine research activities
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R.315-Medicare Sequester COVID Moratorium Act
H.R.3650-Improving Access to Medicare Coverage Act of 2021
H.R.6020-Supporting Medicare Providers Act of 2021
S.2048-Improving Access to Medicare Coverage Act of 2021
S.3314-Supporting Medicare Providers Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
H.R.2079-Eliminating the Provider Relief Fund Tax Penalties Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TEC
16. Specific lobbying issues
H.R.2903-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
S.1512-Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R.3021-Coronavirus Provider Protection Act
H.R.5239-Good Samaritan Health Professionals Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
H.R. 7961-Safety From Violence for Healthcare Employees Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Laura |
Wooster |
|
Senior Vice President, Advocacy and Practice Affairs |
|
Ryan |
McBride |
|
Congressional Affairs Director |
|
Jeanne |
Slade |
|
Director, NEMPAC and ACEP Grassroots Advocacy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |